(Q45962951)
Statements
[Analysis of the efficacy and safety of gefitinib in the treatment of recurrent advanced non-small cell lung cancer in an expanded access program (EAP)] (English)
He Huang
Yang Zhang
Hong-yun Zhao
Zhi-qiang Wang
Fei Xu
Guang-chuan Xu
Li Zhang